Middle East & Africa Genetic Disease Diagnostics Market Size & Outlook
Related Markets
MEA genetic disease diagnostics market highlights
- The MEA genetic disease diagnostics market generated a revenue of USD 336.1 million in 2024.
- The market is expected to grow at a CAGR of 19.7% from 2025 to 2033.
- In terms of segment, next generation sequencing was the largest revenue generating technology in 2024.
- Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 336.1 million |
| Market revenue in 2033 | USD 1,736.5 million |
| Growth rate | 19.7% (CAGR from 2025 to 2033) |
| Largest segment | Next generation sequencing |
| Fastest growing segment | Next Generation Sequencing |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Next Generation Sequencing, Array Technology, PCR - based Testing, FISH |
| Key market players worldwide | Abbott, Celera Motion, ElitechGroup, PerkinElmer, Quest Diagnostics Inc, AutoGenomics, Roche Diagnostics, Biorad Medisys, Transgenomic |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.9% of the global genetic disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,550.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genetic Disease Diagnostics Market Scope
Genetic Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Transgenomic | View profile | 101-250 | Omaha, Nebraska, United States, North America | http://www.transgenomic.com |
| Biorad Medisys | View profile | 501-1000 | Pune, Maharashtra, India, Asia | https://bioradmedisys.com/ |
| AutoGenomics | View profile | 51-100 | Vista, California, United States, North America | http://www.autogenomics.com |
| Roche Diagnostics | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Celera Motion | View profile | 101-250 | Bedford, Massachusetts, United States, North America | https://www.celeramotion.com/ |
| ElitechGroup | View profile | 11-50 | https://www.elitechgroup.co.za/ | |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
Middle East & Africa genetic disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genetic disease diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 61.17% in 2024. Horizon Databook has segmented the Middle East & Africa genetic disease diagnostics market based on next generation sequencing, array technology, pcr - based testing, fish covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa genetic disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa genetic disease diagnostics market databook
-
Our clientele includes a mix of genetic disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa genetic disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa genetic disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA genetic disease diagnostics market size, by country, 2021-2033 (US$M)
Middle East & Africa Genetic Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
